Subcutaneous versus intravenous daratumumab in multiple myeloma – Authors' reply

  1. Mateos, M.-V.
  2. Usmani, S.Z.
Journal:
The Lancet Haematology

ISSN: 2352-3026

Year of publication: 2020

Volume: 7

Issue: 8

Pages: e559

Type: Letter

DOI: 10.1016/S2352-3026(20)30188-5 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals